{"result": ["DRUG", "QALY", "SF-6D", "DOSAGE FORM", "DOSAGE FORM ENHANCE QUALITY", "ANNUAL ESTIMATES", "HEALTH STATUS VARIABLES", "ANNUAL COST", "LONG-TERM IMPACT", "ANTIRETROVIRAL THERAPY", "MEPS", "MULTIPLE FREE DOSE COMBINATION", "EXPENDITURE PANEL SURVEY", "ENHANCE MEDICATION ADHERENCE", "STRATEGY VERSUS", "PROBABILISTIC SIMULATION TECHNIQUE", "SINGLE-PILL STRATEGY", "FXD", "FRC", "ANTIRETROVIRAL FORMULATIONS", "ICUR", "LIFE YEARS", "QALYS", "PILL BURDEN", "SENSITIVITY ANALYSIS", "MEDICAL COSTS", "ANTIRETROVIRAL AGENTS", "SF-12", "COST-UTILITY STUDY", "COMBINING", "VARIOUS ANTIRETROVIRAL AGENTS", "COST-UTILITY RATIOS", "ACTIVE ANTIRETROVIRAL MEDICATIONS", "ICURS", "PROPENSITY SCORES", "MONTE CARLO"]}